Peripheral BDZ Receptor - Biomarker of Neurotoxicity
外周 BDZ 受体 - 神经毒性生物标志物
基本信息
- 批准号:9817320
- 负责人:
- 金额:$ 46.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-19 至 2024-05-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAnimalsAppearanceAstrocytesAttentionBasic ScienceBehaviorBehavioralBenzodiazepine ReceptorBiological MarkersBrainBrain DiseasesBrain InjuriesCatalytic DomainCell membraneCell surfaceCellular biologyChemicalsClinicalClinical ResearchCytokine GeneDisease ProgressionEncephalitisEndoplasmic ReticulumEnvironmental HealthEnzymesEquilibriumExposure toFemaleFlow CytometryGene DeletionGene ExpressionGene ProteinsGlutathioneGoalsHealthHemeHomeostasisHumanImageInjuryKnock-outKnockout MiceKnowledgeLaboratoriesLigandsLipopolysaccharidesMeasuresMediatingMembraneMicrogliaMitochondriaMolecularMovementMusNADPH OxidaseNamesNational Institute of Environmental Health SciencesNerve DegenerationNervous System PhysiologyNeurogliaNeurologicNeurologic EffectOxidation-ReductionOxidative StressPathway interactionsPeripheralPhagocytosisPharmacologyPhysiologic pulsePhysiologyPlayPositron-Emission TomographyProductionProteinsPsyche structureReactive Nitrogen SpeciesReactive Oxygen SpeciesRecoveryResearchRoleSteroid biosynthesisStrategic PlanningStudy SectionTechniquesTherapeuticValidationbasebiological adaptation to stressbiological researchcell motilitycell typeclinical biomarkerscytochrome b558dimerenvironmental chemicalimaging studyimprovedinsightinterestmaleneuroimaging markerneuroinflammationneuropathologyneurotoxicneurotoxicitynovelnovel therapeutic interventionpre-clinicalpreclinical studyprotein expressionprotein protein interactionreceptorresponsesextert-Butylhydroperoxidetherapeutic effectivenessvirtual
项目摘要
Project Summary (Abstract): The long-term goal of this research is to understand the function(s) of
Translocator Protein 18 kDa (TSPO) in glial cells, specifically in microglia. TSPO is a glial stress response
protein that we have previously validated as a biomarker of brain injury and inflammation and it is currently
used in preclinical and clinical Positron Emission Tomography (PET) imaging studies throughout the world.
TSPO is a sensitive biomarker that is able to detect brain injury and neuroinflammation in a number of human
neurodegenerative and mental conditions as well as in neurodegeneration induced by exposures to
environmental chemicals. Furthermore, we are currently using TSPO as a biomarker of neurotoxicity to screen
the neurotoxicity of chemicals for which there is currently no information on their potential to damage the brain.
Despite the widespread use of TSPO in clinical and preclinical studies, there is a paucity of knowledge on the
function(s) of TSPO in glial cells (microglia and astrocytes), the cell types that upregulate TSPO under
neuropathological conditions. This proposal is aimed at understanding a novel interaction that we have
discovered between TSPO and NADPH Oxidase (NOX2) in microglia that may provide important insights on
modulation of brain reactive oxygen species (ROS) production and neuroinflammation. We present rigorously
performed studies demonstrating the TSPO-NOX2 interaction and its modulation by microglia activation. There
are three specific aims in the proposed research. Specific aim 1 will examine the function of TSPO in primary
microglia generated from wildtype and global TSPO knockout (TSPO-gKO) as well as microglia-specific
conditional TSPO (mTSPO-cKO) mice. Specific aim 2 will examine the subcellular localization and functional
significance of the TSPO-NOX2 interaction in microglia. Finally, specific aim 3 will examine the neurological
effects of TSPO deletion (global and microglia-specific) at the whole animal level. Combined, the proposed
studies will generate new information on the function of TSPO in microglia. We will use state-of-the-art
molecular and cellular techniques to understand the function of TSPO in microglia. A precise understanding of
this novel TSPO-NOX2 interaction will provide new insights for devising therapeutics strategies for
neurodegenerative conditions that involve neuroinflammation since NOX2 is involved in microglia-mediated
neurodegeneration. This research topic is consistent with strategic objective 1 in advancing environmental
health sciences basic biological research which is an integral part of the National Institute of Environmental
Health Sciences strategic plan 2018-2023: Advancing Environmental Health Science, Improving Health 2.0.
项目摘要(摘要):这项研究的长期目标是了解
胶质细胞中的转运蛋白18 kDa(TSPO),特别是小胶质细胞。 TSPO是神经胶质应力响应
我们以前已证实是脑损伤和炎症的生物标志物的蛋白质,目前是
用于临床前和临床正电子发射断层扫描(PET)成像研究。
TSPO是一种敏感的生物标志物,能够检测许多人类的脑损伤和神经炎症
神经退行性和精神状况以及在暴露于
环境化学品。此外,我们目前正在使用TSPO作为神经毒性的生物标志物进行筛查
目前尚无有关其损害大脑潜力的化学物质的神经毒性。
尽管TSPO在临床和临床前研究中广泛使用,但关于该研究的知识很少
TSPO在神经胶质细胞(小胶质细胞和星形胶质细胞)中的功能,在下调TSPO的细胞类型
神经病理条件。该提议旨在理解我们有的新颖互动
在小胶质细胞中发现的TSPO和NADPH氧化酶(NOX2)之间,可能会提供有关重要见解的
调节大脑活性氧(ROS)产生和神经炎症。我们严格介绍
进行了研究,证明了TSPO-NOX2相互作用及其通过小胶质细胞激活的调节。那里
在拟议的研究中是三个具体目标。特定的目标1将检查TSPO在初级中的功能
由Wildtype和全球TSPO敲除(TSPO-GKO)以及小胶质细胞特异性产生的小胶质细胞
有条件的TSPO(MTSPO-CKO)小鼠。特定目标2将检查亚细胞定位和功能
小胶质细胞中TSPO-Nox2相互作用的重要性。最后,特定目标3将检查神经系统
TSPO缺失(全球和小胶质细胞特异性)在整个动物水平上的影响。合并,提议
研究将生成有关小胶质细胞中TSPO功能的新信息。我们将使用最先进的
分子和细胞技术了解TSPO在小胶质细胞中的功能。对
这种新颖的TSPO-Nox2相互作用将为设计治疗策略提供新的见解
由于NOX2参与小胶质细胞介导的,涉及神经炎症的神经退行性疾病
神经变性。该研究主题与战略目标1一致,以提高环境
健康科学基础生物学研究是美国国家环境研究所不可或缺的一部分
健康科学战略计划2018-2023:推进环境健康科学,改善健康2.0。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Tomas R Guilarte其他文献
Tomas R Guilarte的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Tomas R Guilarte', 18)}}的其他基金
TSPO and Neuroinflammation in Alzheimer's Disease
TSPO 和阿尔茨海默氏病的神经炎症
- 批准号:
10505310 - 财政年份:2022
- 资助金额:
$ 46.23万 - 项目类别:
Peripheral BDZ Receptor - Biomarker of Neurotoxicity
外周 BDZ 受体 - 神经毒性生物标志物
- 批准号:
10020410 - 财政年份:2019
- 资助金额:
$ 46.23万 - 项目类别:
Peripheral BDZ Receptor - Biomarker of Neurotoxicity
外周 BDZ 受体 - 神经毒性生物标志物
- 批准号:
10176485 - 财政年份:2019
- 资助金额:
$ 46.23万 - 项目类别:
Peripheral BDZ Receptor - Biomarker of Neurotoxicity
外周 BDZ 受体 - 神经毒性生物标志物
- 批准号:
10414054 - 财政年份:2019
- 资助金额:
$ 46.23万 - 项目类别:
Peripheral BDZ Receptor - Biomarker of Neurotoxicity
外周 BDZ 受体 - 神经毒性生物标志物
- 批准号:
10622558 - 财政年份:2019
- 资助金额:
$ 46.23万 - 项目类别:
Cholinergic Neuron Degeneration in Mn Neurotoxicity
锰神经毒性中的胆碱能神经元变性
- 批准号:
9906056 - 财政年份:2018
- 资助金额:
$ 46.23万 - 项目类别:
相似国自然基金
基于扁颅蝠类群系统解析哺乳动物脑容量适应性减小的演化机制
- 批准号:32330014
- 批准年份:2023
- 资助金额:215 万元
- 项目类别:重点项目
基于供应链视角的动物源性食品中抗微生物药物耐药性传导机制及监管策略研究
- 批准号:72303209
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于基因组数据自动化分析为后生动物类群大规模开发扩增子捕获探针的实现
- 批准号:32370477
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
大型野生动物对秦岭山地森林林下植物物种组成和多样性的影响及作用机制
- 批准号:32371605
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
闸坝建设对河口大型底栖动物功能与栖息地演变的影响-以粤西鉴江口为例
- 批准号:42306159
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Impact of obesity on SARS-CoV-2 infection and reciprocal effects of SARS-CoV-2 on metabolic disease
肥胖对 SARS-COV-2 感染的影响以及 SARS-COV-2 对代谢疾病的相互影响
- 批准号:
10583175 - 财政年份:2023
- 资助金额:
$ 46.23万 - 项目类别:
Role of the Infrapatellar Fat Pad in the Development of Post-Traumatic Osteoarthritis Following Blunt Impact to the Knee Joint
髌下脂肪垫在膝关节钝性撞击后发生创伤后骨关节炎中的作用
- 批准号:
10654180 - 财政年份:2023
- 资助金额:
$ 46.23万 - 项目类别:
Opioid-Induced Epigenetic Mechanisms in Glaucoma
阿片类药物诱导的青光眼表观遗传机制
- 批准号:
10563745 - 财政年份:2023
- 资助金额:
$ 46.23万 - 项目类别:
Testing the effects of a selective calpain-2 inhibitor on spontaneous recurrent seizures in mouse models of epilepsy
测试选择性 calpain-2 抑制剂对小鼠癫痫模型自发性复发性癫痫发作的影响
- 批准号:
10696598 - 财政年份:2023
- 资助金额:
$ 46.23万 - 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
- 批准号:
10532480 - 财政年份:2022
- 资助金额:
$ 46.23万 - 项目类别: